» Articles » PMID: 11288971

Factors Predicting Success Rate and Recurrence of Atrial Fibrillation After First Electrical Cardioversion in Patients with Persistent Atrial Fibrillation

Overview
Journal Clin Cardiol
Date 2001 Apr 6
PMID 11288971
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The recurrence rate of atrial fibrillation (AF) after elective cardioversion is high.

Hypothesis: The study aimed to identify clinical predictors for successful electrical cardioversion and maintenance of sinus rhythm after a first electrical cardioversion in patients with persistent AF without concomitant antiarrhythmic drugs of class I and III.

Methods: Consecutive outpatients (n = 166) with persistent AF for > 1 month, scheduled for elective cardioversion, were prospectively included in the study. A clinical investigation, echocardiographic assay, and Holter electrocardiogram (ECG) before and ECG 4 weeks after cardioversion, were performed in all patients.

Results: The mean age of the patients was 68 years (range 45-83) and duration of AF was 5 (1-48) months. Sinus rhythm was established in 124 (75%) patients. In multivariate analysis, only duration of AF < 6 months (p < 0.04, odds ratio [OR] 2.2, 95% confidence interval [CI] 1.1 to 4.7) and patients weight (p < 0.03, OR 2.3, 95% CI 1.1 to 4.8 for weight < 80 kg) were identified as independent predictors of successful cardioversion. At 4 weeks after cardioversion, only 46 (37%) of 124 patients maintained sinus rhythm. Independent factors for maintenance of sinus rhythm, in multivariate analysis, were AF <3 months (p < 0.04, OR 2.5, 95% CI 1.1 to 5.6), treatment with beta blockers (p < 0.00001, OR 7.0, 95% CI 3.0 to 16.3) or verapamil/diltiazem (p < 0.04, OR 3.6, 95% CI 1.1 to 12.1), and right atrial dimension < 37 mm (p < 0.02, OR 5.9, 95% CI 1.4 to 25.4).

Conclusions: In patients with persistent AF, the patient's weight and the duration of AF are independent predictors for a successful cardioversion. Short duration of AF, treatment with beta blockers or verapamil/diltiazem, and right atrial area/dimension are independent predictors for maintenance of sinus rhythm.

Citing Articles

Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department.

Diakantonis A, Verras C, Bezati S, Bistola V, Ventoulis I, Velliou M Biomedicines. 2025; 12(12.

PMID: 39767800 PMC: 11727096. DOI: 10.3390/biomedicines12122895.


Echocardiographic Assessment of Left Atrial Mechanics in Patients with Atrial Fibrillation Undergoing Electrical Cardioversion: A Systematic Review.

Sonaglioni A, Nicolosi G, Bruno A, Lombardo M, Muti P J Clin Med. 2024; 13(21).

PMID: 39518435 PMC: 11546254. DOI: 10.3390/jcm13216296.


Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity: A Randomized Clinical Trial.

Aymond J, Sanchez A, Castine M, Bernard M, Khatib S, Hiltbold A JAMA Cardiol. 2024; 9(7):641-648.

PMID: 38776097 PMC: 11238033. DOI: 10.1001/jamacardio.2024.1091.


Functional tricuspid regurgitation and efficacy of electrical cardioversion in patients with atrial fibrillation and atrial functional mitral regurgitation.

Klimek K, Tworek M, Klocek K, Dolega J, Majta G, Marcinkiewicz K Cardiol J. 2024; 31(6):861-869.

PMID: 38587117 PMC: 11706270. DOI: 10.5603/cj.96311.


Should the Left Atrial Appendage Closure (LAAC) Technique Be the Main Form of Stroke Prevention in Patients With Long-Standing Persistent or Permanent Atrial Fibrillation?.

Amalathasan T, Nagaratnam P, El Dirani M, Nagaratnam J, Kholoki S Cureus. 2024; 16(2):e54256.

PMID: 38496111 PMC: 10944332. DOI: 10.7759/cureus.54256.


References
1.
Kalman J, Tonkin A . Atrial fibrillation: epidemiology and the risk and prevention of stroke. Pacing Clin Electrophysiol. 1992; 15(9):1332-46. DOI: 10.1111/j.1540-8159.1992.tb03143.x. View

2.
Benjamin E, Wolf P, DAgostino R, Silbershatz H, Kannel W, Levy D . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98(10):946-52. DOI: 10.1161/01.cir.98.10.946. View

3.
Shenasa M, Kus T, Fromer M, LeBlanc R, Dubuc M, Nadeau R . Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol. 1988; 62(7):403-7. DOI: 10.1016/0002-9149(88)90967-8. View

4.
COUMEL P, Attuel P, Leclercq J, Friocourt P . [Atrial arrhythmias of vagal or catecholaminergic origin: comparative effects of beta-blocker treatment and the escape phenomenon]. Arch Mal Coeur Vaiss. 1982; 75(4):373-87. View

5.
BJERKELUND C, Orning O . An evaluation of DC shock treatment of atrial arrhythmias. Acta Med Scand. 1968; 184(6):481-91. DOI: 10.1111/j.0954-6820.1968.tb02489.x. View